Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jorgensen

Showing results (351-360 of 567) with videos related to

Pageof 57
Sort By:
BMC Medicine|April 10, 2019
Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort studyAndrea L Jorgensen, Clare Prince, Gail Fitzgerald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2012
Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing miceSusanna Choi, Hang-Rae Kim, Lin Leng, et al.
Journal of the American Chemical Society|February 21, 2015
Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factorPawel Dziedzic, José A Cisneros, Michael J Robertson, et al.
Journal of Clinical Pathology|April 17, 2016
Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agentsLanshan Huang, Guillermo Garcia-Manero, Elias Jabbour, et al.
Frontiers in Pharmacology|June 17, 2017
Effect of Genetic Variability in the <i>CYP4F2</i>, <i>CYP4F11</i>, and <i>CYP4F12</i> Genes on Liver mRNA Levels and Warfarin ResponseJ E Zhang, Kathrin Klein, Andrea L Jorgensen, et al.
Protein Science : a Publication of the Protein Society|July 10, 2020
Structural investigation of 2-naphthyl phenyl ether inhibitors bound to WT and Y181C reverse transcriptase highlights key features of the NNRTI binding siteVincent N Duong, Joseph A Ippolito, Albert H Chan, et al.
Protein Engineering|July 6, 2000
Monte Carlo calculations on HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor 8-Cl TIBO: contribution of the L100I and Y181C variants to protein stability and biological activityM B Smith, M L Lamb, J Tirado-Rives, et al.
Journal of Hepatology|May 6, 2018
WITHDRAWN: Reference intervals for putative biomarkers of drug-induced liver injury and liver regeneration in healthy human volunteersBen Francis, Joanna I Clarke, Lauren E Walker, et al.
Human Pathology|September 11, 2009
Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic studyFaisal A Khokhar, William D Payne, Sameer S Talwalkar, et al.
ACS Catalysis|January 29, 2019
Molecular Dynamics Simulations of a Conformationally Mobile Peptide-Based Catalyst for Atroposelective BrominationXin Cindy Yan, Anthony J Metrano, Michael J Robertson, et al.
Pageof 57

Showing results (351-360 of 567) with videos related to

Sort By:
Pageof 57
BMC Medicine|April 10, 2019
Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort studyAndrea L Jorgensen, Clare Prince, Gail Fitzgerald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2012
Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing miceSusanna Choi, Hang-Rae Kim, Lin Leng, et al.
Journal of the American Chemical Society|February 21, 2015
Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factorPawel Dziedzic, José A Cisneros, Michael J Robertson, et al.
Journal of Clinical Pathology|April 17, 2016
Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agentsLanshan Huang, Guillermo Garcia-Manero, Elias Jabbour, et al.
Frontiers in Pharmacology|June 17, 2017
Effect of Genetic Variability in the <i>CYP4F2</i>, <i>CYP4F11</i>, and <i>CYP4F12</i> Genes on Liver mRNA Levels and Warfarin ResponseJ E Zhang, Kathrin Klein, Andrea L Jorgensen, et al.
Protein Science : a Publication of the Protein Society|July 10, 2020
Structural investigation of 2-naphthyl phenyl ether inhibitors bound to WT and Y181C reverse transcriptase highlights key features of the NNRTI binding siteVincent N Duong, Joseph A Ippolito, Albert H Chan, et al.
Protein Engineering|July 6, 2000
Monte Carlo calculations on HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor 8-Cl TIBO: contribution of the L100I and Y181C variants to protein stability and biological activityM B Smith, M L Lamb, J Tirado-Rives, et al.
Journal of Hepatology|May 6, 2018
WITHDRAWN: Reference intervals for putative biomarkers of drug-induced liver injury and liver regeneration in healthy human volunteersBen Francis, Joanna I Clarke, Lauren E Walker, et al.
Human Pathology|September 11, 2009
Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic studyFaisal A Khokhar, William D Payne, Sameer S Talwalkar, et al.
ACS Catalysis|January 29, 2019
Molecular Dynamics Simulations of a Conformationally Mobile Peptide-Based Catalyst for Atroposelective BrominationXin Cindy Yan, Anthony J Metrano, Michael J Robertson, et al.
Pageof 57